Surgical Site Infection Market Insights and Market Report by DelveInsight

Surgical Site Infection Market Insights and Market Report by DelveInsight

The Surgical Site Infection Market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted SSI symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Surgical Site Infection (SSI) symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.


Surgical Site Infection Overview

Surgical site infection (SSI) is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Besides, SSI can be more severe and can affect tissues under the skin, organs, or implanted material.


Request free sample copy-


List of regions covered in the report

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


List of companies involved in the report

  • Destiny Pharma
  • PolyPid
  • Menarini Group Pharma
  • Botanix Pharma
  • Dr. Reddy’s Laboratories Ltd.
  • Zurex Pharma
  • And many others


Surgical Site Infection (SSI) Diagnosis and Treatment

It covers the details of conventional and current medical therapies and diagnosis available in the Surgical Site Infection (SSI) market to treat the condition. It also provides country-wise treatment guidelines and algorithms across the United States, Europe, and Japan.

The DelveInsight Surgical Site Infection (SSI) market report gives a thorough understanding of SSI symptoms by including disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides SSI symptoms of treatment algorithms and treatment guidelines for SSI symptoms in the US, Europe, and Japan.


Surgical Site Infection Market Report

In many SSIs, the responsible pathogens originate from the patient’s endogenous flora. The causative pathogens depend on the type of surgery. These infections are mainly associated with bacterial colonization, and bacteria like Staphylococcus, Streptococcus, and Pseudomonas are mainly responsible for them.

These bacteria can infect a surgical wound through various forms of contact, such as from the touch of a contaminated caregiver or surgical instrument, through germs in the air, or through germs that are already on or in the body and then spread into the wound. Symptoms like malaise, fever, pain, erythema, increased warmth, serous or serosanguinous fluid are mainly associated with SSIs.


Surgical Site Infection Market Outlook

Market segment of this report is categorized into two sections: prophylactic therapy drug market from overall surgical procedures and surgical site infection (SSI) treatment drug market from SSI patient pool. The global therapeutic market of SSI treatment was estimated to be USD 855 million in 2017.


Surgical Site Infection Market Size

Also, the total market size for prophylaxis treatment was USD 863 Million in 2017. The United States accounted for the highest share of both the market types among the 7MM, which was estimated to be USD 554 Million and USD 306 Million in SSI treatment and Prophylaxis, respectively, in 2017.


Surgical Site Infection Market Drugs

Drug chapter segment of the Surgical Site Infection report encloses the detailed analysis of Surgical Site Infection marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Surgical Site Infection clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.


Surgical Site Infection Market Outlook

The Surgical Site Infection (SSI) market outlook of the report helps build the detailed comprehension of the historic, current and forecasted Surgical Site Infection (SSI) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.


Surgical Site Infection Market Report Scope

  • The report covers the descriptive overview of Surgical Site Infection (SSI), explaining its causes, signs and symptoms, pathophysiology, and currently available therapies
  • Comprehensive insight has been provided into the Surgical Site Infection (SSI) epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Surgical Site Infection (SSI) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Surgical Site Infection (SSI) market; historical and forecasted, is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies by understanding trends shaping and driving the global Surgical Site Infection (SSI) market


Request free sample copy-


Table of content

1. Key Insights

2. Report Introduction

3. Surgical Site Infection Prophylactic Market Overview at a Glance

4. Surgical Site Infection Treatment Market Overview at a Glance

5. Executive Summary of Surgical Site Infection

6. Disease Background and Overview

7. Epidemiology and Patient Population

8. Treatment and Management

8.1. Treatment Algorithm of Surgical Site Infections (SSIs)

9. Prevention

10. Organizations contributing towards Surgical Site Infection

11. Patient Journey

12. Case Report

13. Emerging Therapies

14. Surgical Site Infection: Seven Major Market Analysis

15. Market Drivers

16. Market Barriers

17. SWOT Analysis

18. Unmet Needs

19. Appendix

20. DelveInsight Capabilities

21. Disclaimer

22. About DelveInsight 


Surgical Site Infection Market Report Highlights

  • In the coming years, Surgical Site Infection (SSI) market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Surgical Site Infection (SSI) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for SSI. The launch of emerging therapies will significantly impact the Surgical Site Infection (SSI) market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for SSI.
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities


Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Surgical Site Infection (SSI) market
  • To understand the future market competition in the Surgical Site Infection (SSI) market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Surgical Site Infection (SSI) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Surgical Site Infection (SSI) market
  • To understand the future market competition in the Surgical Site Infection (SSI) market


About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.



Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States